PD-L1 testing in advanced gastric cancer-what physicians who treat this disease must know-a literature review.

Renata D'Alpino Peixoto,Maria Cecilia Mathias-Machado,Alexandre Jácome,Mariana Gil,João Fogacci,Bárbara Sodré, Thaís Passarini,Aline Chaves,Paulo Henrique Diniz,Flora Lino,Alexandre Palladino, Mirela Souto, Ana Carolina de Castro,Bernardo Garicochea

Journal of gastrointestinal oncology（2023）

引用 0|浏览3

暂无评分

摘要

From the emerging predictive biomarkers for immune checkpoint inhibition, PD-L1 has demonstrated a meaningful association between level of expression in tumor microenvironment and the magnitude of benefit derived from immune checkpoint inhibition in GC.

查看译文

关键词

Immunotherapy, gastric cancer (GC), programmed cell death-ligand 1 (PD-L1), literature review

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要